ADVIA Chemistry Urinary Protein Reagent Carryover Causing Incorrect Creatinine Results
A reagent carryover issue in Siemens ADVIA Chemistry urinary protein test kits can cause falsely low creatinine test results. The problem occurs when the creatinine test is run after the protein test on the same system.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a diagnostic reagent with confirmed risk of producing falsely depressed test results that could affect patient care decisions. No illnesses or injuries have been reported. The hazard is confirmed but actual clinical impact has not yet been reported.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP) reagent kits, Material Number 11319151, all lots. Approximately 3,067 units were distributed worldwide, including in the United States.
The recall addresses a potential for reagent carryover from the UCFP test that can impact the Enzymatic Creatinine_2 (ECRE_2) test when performed on the same ADVIA Chemistry analyzer system. If the creatinine test is run after the protein test, falsely depressed (lower than actual) creatinine results may be observed.
Affected facilities include clinical laboratories, hospitals, and diagnostic centers using this reagent in the United States (CA, CO, CT, FL, GA, IA, MD, MI, NJ, NM, NY, OH, PA, SD, TX, UT, VA) and in other countries worldwide.
The recalled product
- Product
- ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), Material Number 11319151, in vitro diagnostic use in the quantitative determination of total protein in human urine and cerebrospinal fluid
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 3,067
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI-DI: 00630414279176
- Lot Numbers: All lots
Distribution
Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
Same hazard · reagent carryover
See all →- HighSiemens Atellica CH diagnostic reagent carryover may cause false laboratory test results
FDA (Devices) · 2023-09-06
- ModerateSiemens Atellica CH Total Protein II Recalled for Reagent Carryover
FDA (Devices) · 2023-09-06
- HighLaboratory diagnostic test may produce inaccurate results from reagent carryover
FDA (Devices) · 2023-09-06
- HighSiemens Atellica CH Analyzer: Reagent Carryover Affecting Magnesium Test Results
FDA (Devices) · 2023-09-06
- HighSiemens Atellica CH LDL Cholesterol analyzer reagent carryover issue
FDA (Devices) · 2023-09-06